Typhus vaccine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by OAbot (talk | contribs) at 22:49, 11 April 2020 (Open access bot: doi added to citation with #oabot.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Typhus vaccine
Typhus vaccine developed by Rudolf Weigl
Vaccine description
TargetTyphus
Vaccine typeInactivated
Clinical data
ATC code
Identifiers
ChemSpider
  • none
 ☒NcheckY (what is this?)  (verify)

Typhus vaccines are vaccines developed to protect against typhus.[1] As of 2020 they are not commercially available.[2][3][4]

One typhus vaccine consists of formaldehyde-inactivated Rickettsia prowazekii. Two doses are injected subcutaneously four weeks apart. Booster doses are required every six to twelve months.

See also

References

  1. ^ Chattopadhyay S, Richards AL (2007). "Scrub typhus vaccines: past history and recent developments". Hum Vaccin. 3 (3): 73–80. doi:10.4161/hv.3.3.4009. PMID 17375000.
  2. ^ "Epidemic Typhus". www.cdc.gov. 7 March 2017. Retrieved 26 March 2017.
  3. ^ "Murine Typhus". www.cdc.gov. Retrieved 26 March 2017.
  4. ^ "Scrub Typhus". www.cdc.gov. 7 March 2017. Retrieved 26 March 2017.